Today: 9 June 2026
Lam Research (LRCX) stock falls again as Nvidia “hangover” hits chip-tool makers
27 February 2026
1 min read

Lam Research (LRCX) stock falls again as Nvidia “hangover” hits chip-tool makers

New York, Feb 27, 2026, 1:58 PM EST — Regular session

  • Lam Research slipped roughly 1.3% around midday, deepening Thursday’s steep decline.
  • Chip stocks dropped as Nvidia’s results didn’t spark a rally across the AI sector, putting a drag on semiconductor equipment shares.
  • Next week, Lam’s investor-conference slots are likely to get close scrutiny as investors look for any signs of demand.

Lam Research shares lost ground Friday, dropping 1.25% to $236.14 by midday. The chipmaking-equipment company has been under some pressure.

Lam shares tracked a wider retreat in chip names, with Nvidia’s latest results not lighting a fresh fire under the AI rally. The Philadelphia SE Semiconductor index dropped 3.2% Thursday, dragging down the Nasdaq’s tech-heavy lineup.

Investor focus has shifted: they’re after proof that all this spending delivers results. “This puts a focus on Nvidia’s guidance… and questions around enterprise ROI (return on investment),” said eMarketer analyst Jacob Bourne. Morgan Stanley’s Joseph Moore, for his part, pointed to those familiar worries about growth losing steam. Reuters

Lam shares slid 4.17% Thursday, finishing at $239.07—well off the intraday high of $256.68 hit on Wednesday. Applied Materials also sold off, down 4.87% for the session, as chip-equipment stocks continued to feel the squeeze from cutbacks in factory spending.

Lam, which supplies etch and deposition equipment for advanced chipmaking, put out its March-quarter guidance late last month: $5.7 billion in revenue, give or take $300 million, and adjusted earnings of $1.35 a share, plus or minus 10 cents. Both figures landed above what analysts were expecting.

But here’s the risk laid bare: if investors start to think AI infrastructure spending has already hit its high-water mark—or if it just takes more time to convert that spending into real profits—the high-beta equipment stocks could remain stuck in a rut. For Lam and its rivals, any stumble in memory demand or a squeeze in customer budgets tends to show up quickly in tool orders.

Next up for Lam: CFO Doug Bettinger is scheduled to present at the Morgan Stanley TMT Conference on March 3, then he’s on the agenda for the Cantor Global Technology & Industrial Growth Conference March 11.

Traders are tuning in for signs of shifting customer demand, keeping an eye on China exposure and margins. They’re also watching to see if the chip sector finds its footing after Nvidia’s post-earnings tumble triggered another wave of selling.

Stock Market Today

  • Investment Fund Outperforms with Focus on Affordable AI Stocks
    June 9, 2026, 10:50 AM EDT. A diversified investment fund specializing in cheap AI stocks has outperformed the broader market, demonstrating the benefits of a closed-end fund structure. These funds typically have a fixed number of shares, allowing managers more flexibility to focus on long-term gains rather than daily redemptions. The strategy prioritizes exposure to undervalued artificial intelligence companies, capturing growth potential while managing risk. This performance underscores the appeal of integrating AI sector opportunities within a closed-end investment vehicle for investors seeking market-beating returns.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
Oracle (ORCL) stock price drops as AI-spending doubts bite again, with March earnings next test
Previous Story

Oracle (ORCL) stock price drops as AI-spending doubts bite again, with March earnings next test

Borsa Istanbul’s BIST 100 ended the week lower — here’s what matters before Monday’s open
Next Story

Borsa Istanbul’s BIST 100 ended the week lower — here’s what matters before Monday’s open

Go toTop